(Q37211764)

English

Somatostatin receptor subtypes 2 and 5 are associated with better survival in operable hepatitis B-related hepatocellular carcinoma following octreotide long-acting release treatment

scientific article published on July 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 August 2017

Somatostatin receptor subtypes 2 and 5 are associated with better survival in operable hepatitis B-related hepatocellular carcinoma following octreotide long-acting release treatment (English)

1 reference

Europe PubMed Central

19 August 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

Yao Liu

1

1 reference

Europe PubMed Central

19 August 2017

Li Jiang

2

1 reference

Europe PubMed Central

19 August 2017

Yi Mu

3

1 reference

Europe PubMed Central

19 August 2017

publication date

1 July 2013

1 reference

Europe PubMed Central

19 August 2017

Oncology Letters

1 reference

Europe PubMed Central

19 August 2017

6

1 reference

Europe PubMed Central

19 August 2017

3

1 reference

Europe PubMed Central

19 August 2017

821-828

1 reference

Europe PubMed Central

19 August 2017

Hepatocellular carcinoma in the Asia pacific region

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789087

9 September 2017

Long acting octreotide in the treatment of advanced hepatocellular cancer and overexpression of somatostatin receptors: randomized placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789087

9 September 2017

Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789087

9 September 2017

Rationale for the use of somatostatin analogs as antitumor agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789087

9 September 2017

Perspectives of new potential therapeutic applications of somatostatin analogs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789087

9 September 2017

Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789087

9 September 2017

Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789087

9 September 2017

Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789087

9 September 2017

Regulatory peptide receptors in human hepatocellular carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789087

9 September 2017

Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789087

9 September 2017

Prediction and prevention of intrahepatic recurrence of hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789087

14 September 2017

Overexpression of SSTR2 inhibited the growth of SSTR2-positive tumors via multiple signaling pathways

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789087

14 September 2017

Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789087

14 September 2017

Anti-angiogenic effects of somatostatin receptor subtype 2 on human pancreatic cancer xenografts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789087

14 September 2017

Characterization of somatostatin receptor expression in human pancreatic cancer using real-time RT-PCR.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789087

14 September 2017

Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789087

28 September 2017

Overexpression and functional relevance of somatostatin receptor-1, -2, and -5 in endometrium and endometriotic lesions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789087

3 September 2018

TNM seventh edition: what's new, what's changed: communication from the International Union Against Cancer and the American Joint Committee on Cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789087

3 September 2018

A somatostatin analogue, octreotide, inhibits the occurrence of second primary tumors and lung metastasis after resection of hepatocellular carcinoma in mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789087

3 September 2018

Treatment of advanced hepatocellular carcinoma with long-acting octreotide: a phase III multicentre, randomised, double blind placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789087

3 September 2018

Long-acting octreotide versus placebo for treatment of advanced HCC: a randomized controlled double-blind study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789087

3 September 2018

Differential expression of somatostatin receptor subtypes in hepatocellular carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789087

3 September 2018

Measurement of somatostatin receptor subtype 2 mRNA in breast cancer and corresponding normal tissue

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789087

3 September 2018

The results of a randomized study on the use of long-acting octreotide in hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789087

3 September 2018

The role of sandostatin LAR in treating patients with advanced hepatocellular cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789087

3 September 2018

A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789087

3 September 2018

Treatment of hepatocellular carcinoma with long acting somatostatin analogues.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789087

3 September 2018

Epidemiology of Hepatocellular Carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789087

4 December 2018

Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential expression of five somatostatin receptor subtypes, SSTR1-5, in the CNS and peripheral tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative evaluation of somatostatin receptor subtype 2 expression in sporadic colorectal tumor and in the corresponding normal mucosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of insulin receptors and IGF-I receptors in cancer and other diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitation of somatostatin receptor type 2 gene expression in neuroblastoma cell lines and primary tumors using competitive reverse transcription-polymerase chain reaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Correlation of somatostatin receptor expression in human hepatocellular carcinoma tissue to serum alpha-fetoprotein concentration]

1 reference

https://pubmed.ncbi.nlm.nih.gov/24137418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3892/OL.2013.1435

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37211764&oldid=2127436739"